NO20022663L - Substituerte ftalocyaniner og deres forlöpere - Google Patents

Substituerte ftalocyaniner og deres forlöpere

Info

Publication number
NO20022663L
NO20022663L NO20022663A NO20022663A NO20022663L NO 20022663 L NO20022663 L NO 20022663L NO 20022663 A NO20022663 A NO 20022663A NO 20022663 A NO20022663 A NO 20022663A NO 20022663 L NO20022663 L NO 20022663L
Authority
NO
Norway
Prior art keywords
substituted
phthalonitrile
phthalocyanines
substituted phthalocyanines
precursors
Prior art date
Application number
NO20022663A
Other languages
English (en)
Norwegian (no)
Other versions
NO20022663D0 (no
Inventor
Michael John Cook
Martin James Heeney
Original Assignee
Gentian As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9929064.5A external-priority patent/GB9929064D0/en
Priority claimed from GBGB0025817.8A external-priority patent/GB0025817D0/en
Application filed by Gentian As filed Critical Gentian As
Publication of NO20022663D0 publication Critical patent/NO20022663D0/no
Publication of NO20022663L publication Critical patent/NO20022663L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/22—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains four or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A61K41/0057—Photodynamic therapy with a photosensitizer, i.e. agent able to produce reactive oxygen species upon exposure to light or radiation, e.g. UV or visible light; photocleavage of nucleic acids with an agent
    • A61K41/0071—PDT with porphyrins having exactly 20 ring atoms, i.e. based on the non-expanded tetrapyrrolic ring system, e.g. bacteriochlorin, chlorin-e6, or phthalocyanines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A61K41/0057—Photodynamic therapy with a photosensitizer, i.e. agent able to produce reactive oxygen species upon exposure to light or radiation, e.g. UV or visible light; photocleavage of nucleic acids with an agent
    • A61K41/0076—PDT with expanded (metallo)porphyrins, i.e. having more than 20 ring atoms, e.g. texaphyrins, sapphyrins, hexaphyrins, pentaphyrins, porphocyanines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/08—Drugs for disorders of the urinary system of the prostate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B82—NANOTECHNOLOGY
    • B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y10/00—Nanotechnology for information processing, storage or transmission, e.g. quantum computing or single electron logic
    • C—CHEMISTRY; METALLURGY
    • C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09B—ORGANIC DYES OR CLOSELY-RELATED COMPOUNDS FOR PRODUCING DYES, e.g. PIGMENTS; MORDANTS; LAKES
    • C09B47/00—Porphines; Azaporphines
    • C09B47/04—Phthalocyanines abbreviation: Pc
    • C09B47/045—Special non-pigmentary uses, e.g. catalyst, photosensitisers of phthalocyanine dyes or pigments
    • C—CHEMISTRY; METALLURGY
    • C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09B—ORGANIC DYES OR CLOSELY-RELATED COMPOUNDS FOR PRODUCING DYES, e.g. PIGMENTS; MORDANTS; LAKES
    • C09B47/00—Porphines; Azaporphines
    • C09B47/04—Phthalocyanines abbreviation: Pc
    • C09B47/06—Preparation from carboxylic acids or derivatives thereof, e.g. anhydrides, amides, mononitriles, phthalimide, o-cyanobenzamide
    • C09B47/067—Preparation from carboxylic acids or derivatives thereof, e.g. anhydrides, amides, mononitriles, phthalimide, o-cyanobenzamide from phthalodinitriles naphthalenedinitriles, aromatic dinitriles prepared in situ, hydrogenated phthalodinitrile
    • C—CHEMISTRY; METALLURGY
    • C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09B—ORGANIC DYES OR CLOSELY-RELATED COMPOUNDS FOR PRODUCING DYES, e.g. PIGMENTS; MORDANTS; LAKES
    • C09B47/00—Porphines; Azaporphines
    • C09B47/04—Phthalocyanines abbreviation: Pc
    • C09B47/06—Preparation from carboxylic acids or derivatives thereof, e.g. anhydrides, amides, mononitriles, phthalimide, o-cyanobenzamide
    • C09B47/067—Preparation from carboxylic acids or derivatives thereof, e.g. anhydrides, amides, mononitriles, phthalimide, o-cyanobenzamide from phthalodinitriles naphthalenedinitriles, aromatic dinitriles prepared in situ, hydrogenated phthalodinitrile
    • C09B47/0673—Preparation from carboxylic acids or derivatives thereof, e.g. anhydrides, amides, mononitriles, phthalimide, o-cyanobenzamide from phthalodinitriles naphthalenedinitriles, aromatic dinitriles prepared in situ, hydrogenated phthalodinitrile having alkyl radicals linked directly to the Pc skeleton; having carbocyclic groups linked directly to the skeleton

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hematology (AREA)
  • Cardiology (AREA)
  • Nanotechnology (AREA)
  • Rheumatology (AREA)
  • Epidemiology (AREA)
  • Urology & Nephrology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Dermatology (AREA)
  • Diabetes (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Mathematical Physics (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Theoretical Computer Science (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Virology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Pain & Pain Management (AREA)
  • Immunology (AREA)
  • Vascular Medicine (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NO20022663A 1999-12-08 2002-06-05 Substituerte ftalocyaniner og deres forlöpere NO20022663L (no)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GBGB9929064.5A GB9929064D0 (en) 1999-12-08 1999-12-08 Substituted phthalocyanines and their precursors
GB0012348A GB0012348D0 (en) 1999-12-08 2000-05-22 Substituted phthalocyanines and their precursors
GBGB0025817.8A GB0025817D0 (en) 1999-12-08 2000-10-20 Substituted phthalocyanines and their precursors
PCT/GB2000/004708 WO2001042368A1 (en) 1999-12-08 2000-12-08 Substituted phthalocyanines and their precursors

Publications (2)

Publication Number Publication Date
NO20022663D0 NO20022663D0 (no) 2002-06-05
NO20022663L true NO20022663L (no) 2002-08-08

Family

ID=27255732

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20022663A NO20022663L (no) 1999-12-08 2002-06-05 Substituerte ftalocyaniner og deres forlöpere

Country Status (10)

Country Link
EP (1) EP1238016A1 (pl)
JP (1) JP2003516421A (pl)
AU (1) AU2192201A (pl)
CA (1) CA2394891A1 (pl)
CZ (1) CZ20021974A3 (pl)
EE (1) EE200200298A (pl)
HU (1) HUP0301099A3 (pl)
NO (1) NO20022663L (pl)
PL (1) PL355851A1 (pl)
WO (1) WO2001042368A1 (pl)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1381611B1 (en) * 2001-03-21 2005-06-22 L. MOLTENI & C. DEI FRATELLI ALITTI SOCIETA' DI ESERCIZIO SOCIETA' PER AZIONI Metal substituted non centrosimmetrical phthalocyanine analogues, their preparation and use in photodynamic therapy and in vivo diagnostic
US7091373B2 (en) 2002-03-18 2006-08-15 Sumitomo Chemical Company, Limited Production method for biarylalanine
CN100415715C (zh) * 2003-02-11 2008-09-03 杜锡光 紫菜嗪环中具有六个异吲哚结构亚单元的超酞菁类化合物、合成方法及用途
NZ543565A (en) * 2003-05-14 2008-12-24 Univ Sherbrooke Amphiphilic trisulfonated porphyrazines for photodynamic applications in medicine
JP4809657B2 (ja) * 2005-09-29 2011-11-09 富士フイルム株式会社 ナフタロシアニン色素およびその製造方法
JP4942351B2 (ja) * 2006-01-31 2012-05-30 独立行政法人科学技術振興機構 光線力学治療抗癌剤
JP5296355B2 (ja) * 2007-09-11 2013-09-25 株式会社日本触媒 アリール基含有フタロシアニン化合物、その製造方法、及び、配合物
US8168359B2 (en) * 2008-03-10 2012-05-01 Xerox Corporation Nanosized particles of phthalocyanine pigments
CZ303612B6 (cs) * 2010-08-19 2013-01-09 Výzkumný ústav organických syntéz a.s. Sloucenina pro fotodynamickou inaktivaci soucasne grampozitivních bakterií, gramnegativních bakterií a patogenních kvasinek, na bázi derivátu ftalocyaninu, a pouzití této slouceniny
JP2012167189A (ja) * 2011-02-14 2012-09-06 Aisin Seiki Co Ltd フタロシアニン誘導体、フタロシアニン誘導体の製造方法および色素増感型太陽電池
JP2013193956A (ja) * 2012-03-15 2013-09-30 Saitama Univ ｔｅｔｒａｋｉｓ−トリアルキルまたはフェニルシリルエチニル置換フタロシアニンおよびその製造方法
JP6278386B2 (ja) * 2013-11-06 2018-02-14 国立研究開発法人産業技術総合研究所 フタロシアニン化合物及び有機半導体材料
CN103864645B (zh) * 2013-12-30 2016-08-17 常州大学 一种二取代全氟烷基邻苯二甲腈化合物及其制备方法
CN104016995A (zh) * 2014-06-26 2014-09-03 常州大学 八取代全氟烷基钴酞菁化合物及其制备方法
JP6608187B2 (ja) * 2015-06-22 2019-11-20 山本化成株式会社 増感色素、半導体電極、光電変換素子および色素増感太陽電池
EP3287451B1 (de) 2016-08-24 2019-12-11 Cynora Gmbh Organische moleküle, insbesondere zur verwendung in organischen optoelektronischen vorrichtungen
CN108017650A (zh) * 2017-03-08 2018-05-11 先尼科化工（上海）有限公司 一种用于滤光片的酞菁化合物及其制备方法和应用方法
JP6922361B2 (ja) * 2017-04-07 2021-08-18 Jsr株式会社 固体撮像素子用組成物、赤外線遮蔽膜及び固体撮像素子
JP7128804B2 (ja) * 2017-04-07 2022-08-31 山本化成株式会社 ナフタロシアニン化合物、その製造方法および用途
CN110494501B (zh) * 2017-04-07 2022-04-19 山本化成株式会社 酞菁系化合物、及其用途
WO2020071470A1 (ja) * 2018-10-05 2020-04-09 山本化成株式会社 フタロシアニン系化合物、及びその用途
CN112279856B (zh) * 2019-07-24 2021-09-17 南方科技大学 一种非外围取代的可溶性金属酞菁及其合成方法和应用、一种钙钛矿太阳能电池
CN112014383B (zh) * 2020-06-30 2024-03-29 杜旭忠 一种用于均相化学发光的光敏剂及其制备方法和应用
JP7721536B2 (ja) * 2020-07-31 2025-08-12 住友化学株式会社 化合物
CN112812299B (zh) * 2020-12-31 2022-03-29 四川大学 邻苯二甲腈与氨基酸环肽共聚树脂及其制备方法
WO2022196089A1 (ja) * 2021-03-15 2022-09-22 ソニーグループ株式会社 リポソーム複合体、物質送達システム、物質送達方法及び光照射装置
EP4574911A1 (en) 2023-12-22 2025-06-25 Holland Colours N. V. Bio-sourced phthalocyanine complex, preparation and use thereof

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0155780B1 (en) * 1984-03-21 1990-03-28 Imperial Chemical Industries Plc Infra-red absorber
GB8431446D0 (en) * 1984-12-13 1985-01-23 Secr Defence Alkoxyphthalocyanines
GB8619238D0 (en) * 1986-08-06 1986-09-17 Ici Plc Organic photoconductor
EP0346354B1 (en) * 1987-02-13 1992-08-19 The Secretary of State for Defence in Her Britannic Majesty's Government of the United Kingdom of Great Britain and Substituted phthalocyanines
JPH0730300B2 (ja) * 1988-04-01 1995-04-05 三井東圧化学株式会社 アルキルフタロシアニン近赤外線吸収剤及びそれを用いた表示・記録材料
DE68928559T2 (de) * 1988-12-15 1998-06-18 Mitsui Toatsu Chemicals Absorbiermittel im nahen Infrarot und Anzeige-/Aufzeichnungsmaterialien, die daraus hergestellt sind
JPH07103093B2 (ja) * 1989-01-12 1995-11-08 三井東圧化学株式会社 フタロニトリル系化合物およびその製造方法
DE69228502T2 (de) * 1991-06-19 1999-08-12 Mitsui Chemicals, Inc., Tokio/Tokyo Phthalocyaninverbindungen und ihre Verwendung
SG47881A1 (en) * 1991-11-08 1998-04-17 Eastman Chem Co Method for tagging thermoplastic materials with near infrared fluorophores
GB9317881D0 (en) * 1993-08-27 1993-10-13 Secr Defence Photosensitizers
US5456998A (en) * 1994-04-26 1995-10-10 Xerox Corporation Photoconductive imaging members containing alkoxy-bridged metallophthalocyanine dimers
JPH0892190A (ja) * 1994-09-26 1996-04-09 Kanto Chem Co Inc シアノビフェニル誘導体並びにそれらを含む液晶組成物
GB9613476D0 (en) * 1996-06-27 1996-08-28 British Polythene Ltd Improvements in or relating to films and/or coatings
IT1294325B1 (it) * 1997-08-14 1999-03-24 Molteni L E C Dei Fratelli Ali Zinco-ftalocianine e relativi coniugati, preparazione e uso nella terapia fotodinamica e come diagnostici
US6511971B1 (en) * 1998-10-13 2003-01-28 Brown University Research Foundation Substituted perhalogenated phthalocyanines

Also Published As

Publication number Publication date
HUP0301099A2 (hu) 2003-08-28
PL355851A1 (pl) 2004-05-31
EP1238016A1 (en) 2002-09-11
CZ20021974A3 (cs) 2002-11-13
AU2192201A (en) 2001-06-18
NO20022663D0 (no) 2002-06-05
WO2001042368A1 (en) 2001-06-14
CA2394891A1 (en) 2001-06-14
HUP0301099A3 (en) 2003-11-28
JP2003516421A (ja) 2003-05-13
EE200200298A (et) 2003-08-15

Similar Documents

Publication Publication Date Title
NO20022663L (no) Substituerte ftalocyaniner og deres forlöpere
AU2002341989A1 (en) Process to produce derivatives from uk-2a derivatives
MXPA03011329A (es) Antiinfecciosos novedosos.
AU2001288066A1 (en) Process for production of aromatic polycarbonates
WO2002030870A3 (de) Substituierte c-cyclohexylmethylamin-derivate
WO2002010152A3 (de) Neue indolderivate und deren verwendung als arzneimittel
AU2002333347A1 (en) Process for the production of scleroglucan
NO20016151L (no) Fremstilling av substituerte piperidin-4-oner
AU1342001A (en) Enhancement of production of camptothecins from plants
IL158998A0 (en) Process for the production of 4-amino-2, 5-bisheterocyclylquinazolines
AU2001246949A1 (en) Process of culturing algae
PT1307436E (pt) Processo para a preparacao de derivados de bacatina iii
WO2002046152A3 (de) Coniosetin und derivate davon, verfahren zur herstellung und verwendung derselben
WO2000064882A3 (en) Enantiomers of mercapto lactones and processes for their synthesis
NO20020308D0 (no) Fremgangsmåte for fremstilling av epothiolon B og derivater, såvel som mellomprodukter for fremgangsmåten
AU2001292236A1 (en) 5-phenylbenzylamine compounds, process for their production and intermediates for their synthesis
AU2002336564A1 (en) Method of enzyme production by microorganisms
AU2002335992A1 (en) Process for the production of ascopyrone p
PT1341924E (pt) Processo para a producao de biomassa
AU2002226018A1 (en) Process for the production of diaryl carbonates
YU67203A (sh) Derivati caloporosida, postupak za njihovu proizvodnju i njihova primena
NO20041537L (no) Fremgangsmate ved fremstilling av 14beta-hydroksy-baccatin III-1, 14-karbonat
AU2002216685A1 (en) Process for the production of diaryl carbonates
AU5925498A (en) Processes for producing 3-cyanopyridine from 2-methyl-1,5-pentanediamine
AU2002301062A1 (en) Novel pulping method to improve the quality of recycled fibers

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application